Complete Filing Data
Agriculture & Natural Solutions Acquisition Corp reported Stockholders Equity of -$29.19 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Agriculture & Natural Solutions Acquisition Corp did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Net Income * | $10.5M | $8.4M | $1.3M | -$1.2K |
| Operating Income Loss | -$5.5M | -$10.2M | -$1.2M | -$1.2K |
| General And Administrative Expense | $5.5M | $10.2M | $1.2M | $1.2K |
| General And Administrative Expenses Funded By Note Payable To Sponsor And Affiliates | $7.6M | $2.8M | ||
| Formation And Operating Expenses Funded By Note Payable Through Sponsor | $1.2K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q1 2023 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|
| Net Income * | $3.4M | -$131.9K | $4.0M | $490.6K | $2.2M | $4.1M | -$698.00 | -$599.00 |
| Operating Income Loss | -$737.2K | -$4.2M | $39.8K | -$4.3M | -$2.5M | -$551.3K | -$698.00 | |
| General And Administrative Expense | $737.2K | $4.2M | -$39.8K | $4.3M | $2.5M | $551.3K | $698.00 | |
| General And Administrative Expenses Funded By Note Payable To Sponsor And Affiliates | $1.3M | |||||||
| Formation And Operating Expenses Funded By Note Payable Through Sponsor | $698.00 |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Stockholders Equity | -$29.2M | -$22.4M | -$12.1M | $15.4K | $16.6K |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $1.00 | $1.00 | $284.8K | $20.0K | |
| Retained Earnings Accumulated Deficit | -$29.2M | -$22.4M | -$12.1M | -$9.6K | |
| Liabilities Current | $17.3M | $10.6M | $239.1K | $759.0K | |
| Liabilities And Stockholders Equity | $366.2M | $366.3M | $348.2M | $774.4K | |
| Interest Income Operating Paid In Cash | $16.0M | $18.6M | $2.5M | ||
| Assets | $366.2M | $366.3M | $348.2M | $774.4K | |
| Liabilities | $29.4M | $22.6M | $12.9M | $759.0K | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $0.00 | -$284.8K | $264.8K | $20.0K | |
| Assets Current | $214.5K | $273.2K | $765.2K | $20.0K | |
| Deferred Underwriting Fees Payable Non Current | $12.1M | $12.1M | $12.1M | ||
| Assets Held In Trust Noncurrent | $366.0M | $366.1M | $347.5M | ||
| Accrued Liabilities Current | $0.00 | $5.6K | $440.8K | ||
| Repayments Of Related Party Debt | $0.00 | $584.8K | $691.3K | ||
| Preferred Stock Value | $0.00 | $0.00 | |||
| Additional Paid In Capital Common Stock | $0.00 | $0.00 | $24.1K | ||
| Deferred Legal Fee Current | $6.9M | $6.9M | |||
| Deferred Legal Fee Noncurrent | $584.0K | ||||
| Notes Payable Current | $300.0K | ||||
| Repayments Of Notes Payable | $300.0K | ||||
| Offering Costs Included In Deferred Legal Fees | $145.4K | ||||
| Offering Costs Included In Accrued Expenses | $183.6K | ||||
| Offering Costs Included In Accounts Payable | $13.3K | ||||
| Deferred Underwriting Fees Payable | $12.1M | ||||
| Deferred Offering Costs | |||||
| Deferred Costs | $754.4K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | -$27.3M | -$26.5M | -$22.3M | -$19.5M | -$15.2M | -$12.7M | $14.7K | $14.7K | $14.7K | $16.0K | $16.6K | $16.6K | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $1.00 | $1.00 | $1.00 | $1.00 | $0.00 | $235.7K | $20.0K | $20.0K | ||||||
| Retained Earnings Accumulated Deficit | -$27.3M | -$26.5M | -$22.3M | -$19.5M | -$15.2M | -$12.7M | -$10.3K | |||||||
| Liabilities Current | $15.2M | $14.6M | $10.5M | $2.6M | $426.8K | $394.1K | $1.2M | |||||||
| Liabilities And Stockholders Equity | $378.3M | $374.3M | $370.3M | $362.2M | $357.2M | $352.8M | $1.2M | |||||||
| Interest Income Operating Paid In Cash | $4.2M | $4.1M | $4.0M | $4.8M | $4.8M | $4.7M | ||||||||
| Assets | $378.3M | $374.3M | $370.3M | $362.2M | $357.2M | $352.8M | $1.2M | |||||||
| Liabilities | $27.3M | $26.7M | $22.6M | $20.0M | $15.5M | $13.3M | ||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$49.0K | |||||||||||||
| Assets Current | $48.1K | $153.9K | $216.5K | $441.9K | $346.8K | $649.4K | ||||||||
| Deferred Underwriting Fees Payable Non Current | $12.1M | $12.1M | $12.1M | $12.1M | $12.1M | $12.1M | ||||||||
| Assets Held In Trust Noncurrent | $378.2M | $374.1M | $370.0M | $361.7M | $356.9M | $352.1M | ||||||||
| Accrued Liabilities Current | $33.3K | $22.9K | $2.9K | $54.2K | $41.3K | $4.3K | $526.1K | |||||||
| Repayments Of Related Party Debt | $349.0K | |||||||||||||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||||
| Additional Paid In Capital Common Stock | $0.00 | $0.00 | $0.00 | $24.1K | ||||||||||
| Deferred Legal Fee Current | $6.6M | $6.2M | $6.0M | |||||||||||
| Deferred Legal Fee Noncurrent | $5.3M | $3.0M | $864.4K | |||||||||||
| Notes Payable Current | $300.0K | |||||||||||||
| Repayments Of Notes Payable | ||||||||||||||
| Offering Costs Included In Deferred Legal Fees | ||||||||||||||
| Offering Costs Included In Accrued Expenses | ||||||||||||||
| Offering Costs Included In Accounts Payable | ||||||||||||||
| Deferred Underwriting Fees Payable | ||||||||||||||
| Deferred Offering Costs | $1.2M | $754.4K | ||||||||||||
| Deferred Costs |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Net Cash Provided By Used In Financing Activities | -$17.4M | -$284.8K | $346.4M | $20.0K |
| Net Cash Provided By Used In Operating Activities | $1.3M | $1.00 | -$1.2M | |
| Increase Decrease In Prepaid Expense | -$58.7K | -$207.2K | $480.4K | |
| Increase Decrease In Deferred Legal Fees | $25.7K | -$6.4M | -$438.6K | |
| Increase Decrease In Accrued Liabilities | -$5.6K | $5.6K | ||
| Increase Decrease In Accounts Payable | -$812.6K | $844.7K | $11.5K | |
| Net Cash Provided By Used In Investing Activities | $16.1M | $0.00 | -$345.0M | |
| Proceeds From Sale Of Class A Units Gross | $345.0M | |||
| Proceeds From Issuance Of Private Placement | $9.4M | |||
| Payments To Acquire Trust Preferred Investments | $345.0M | |||
| Payments Of Stock Issuance Costs | $7.0M | |||
| Proceeds From Refund Of Offering Costs Paid By Sponsor | $20.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 |
|---|---|---|
| Net Cash Provided By Used In Financing Activities | $144.6K | |
| Net Cash Provided By Used In Operating Activities | -$193.6K | |
| Increase Decrease In Prepaid Expense | -$56.7K | -$66.8K |
| Increase Decrease In Deferred Legal Fees | $952.0K | -$280.4K |
| Increase Decrease In Accrued Liabilities | -$2.7K | $4.3K |
| Increase Decrease In Accounts Payable | -$449.4K | $6.2K |
| Net Cash Provided By Used In Investing Activities | ||
| Proceeds From Sale Of Class A Units Gross | ||
| Proceeds From Issuance Of Private Placement | ||
| Payments To Acquire Trust Preferred Investments | ||
| Payments Of Stock Issuance Costs | ||
| Proceeds From Refund Of Offering Costs Paid By Sponsor |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2022 |
|---|---|---|---|
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 |
| Preferred Stock Shares Authorized | 5.0M | 5.0M | 5.0M |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 |
| Weighted Average Number Of Shares Outstanding Basic | |||
| Weighted Average Number Of Diluted Shares Outstanding | |||
| Earnings Per Share Diluted | |||
| Earnings Per Share Basic |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Preferred Stock Shares Authorized | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Weighted Average Number Of Shares Outstanding Basic | 7.5M | 7.5M | |||||||
| Weighted Average Number Of Diluted Shares Outstanding | 7.5M | 7.5M | |||||||
| Earnings Per Share Diluted | $0.00 | $0.00 | |||||||
| Earnings Per Share Basic | $0.00 | $0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Remeasurement Of Class A Oridinare Shares To Redemption Value | -17.3M | -18.6M | -24.9M | |
| Prepaid Expense Current | $214.5K | $273.2K | $480.4K | |
| Advaces From Related Party | $0.00 | -$300.0K | ||
| Waived Legal Fees | ||||
| Offering Costs Paid Through Promissory Note Related Party | $145.6K | |||
| Formation Costs | ||||
| Working Capital Promissory Notes | $1.5M | $1.5M | ||
| Trust Account Withdrawal Redemption | $17.4M | $0.00 | ||
| Stock Repurchased During Period Value | ||||
| Related Party Transaction Purchases From Related Party | ||||
| Redemption Of Class A Ordinary Shares | 17.4M | 0.00 | ||
| Extension Promissory Notes | $1.3M | $0.00 | ||
| Extension Contribution Deposit Into Trust Account | $1.3M | $0.00 | ||
| Adjustments To Additional Paid In Capital Warrant Issued | $9.4M | |||
| Adjustments To Additional Paid In Capital Other Offering Costs | -$166.5K | |||
| Adjustments To Additional Paid In Capital Allocation Of IPO Proceeds To Public Warrants | $2.2M | |||
| Stock Repurchased And Retired During Period Value |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q1 2023 | Q3 2022 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Remeasurement Of Class A Oridinare Shares To Redemption Value | -4.2M | -4.1M | -4.0M | -4.8M | -4.8M | -4.7M | ||||
| Prepaid Expense Current | $48.1K | $153.9K | $216.5K | $441.9K | $346.8K | $413.6K | ||||
| Advaces From Related Party | -$493.6K | |||||||||
| Waived Legal Fees | $0.00 | $2.1M | $0.00 | |||||||
| Offering Costs Paid Through Promissory Note Related Party | $39.5K | |||||||||
| Formation Costs | $599.00 | |||||||||
| Working Capital Promissory Notes | ||||||||||
| Trust Account Withdrawal Redemption | ||||||||||
| Stock Repurchased During Period Value | $0.00 | $0.00 | ||||||||
| Related Party Transaction Purchases From Related Party | $493.6K | |||||||||
| Redemption Of Class A Ordinary Shares | ||||||||||
| Extension Promissory Notes | ||||||||||
| Extension Contribution Deposit Into Trust Account | ||||||||||
| Adjustments To Additional Paid In Capital Warrant Issued | ||||||||||
| Adjustments To Additional Paid In Capital Other Offering Costs | ||||||||||
| Adjustments To Additional Paid In Capital Allocation Of IPO Proceeds To Public Warrants | ||||||||||
| Stock Repurchased And Retired During Period Value | $0.00 |
Most recent annual filing with the SEC: March 27, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.